Cerqueira-Silva, Thiago https://orcid.org/0000-0003-4534-2509
Katikireddi, Srinivasa Vittal https://orcid.org/0000-0001-6593-9092
de Araujo Oliveira, Vinicius https://orcid.org/0000-0001-7858-9650
Flores-Ortiz, Renzo https://orcid.org/0000-0001-7639-2627
Júnior, Juracy Bertoldo
Paixão, Enny S. https://orcid.org/0000-0002-4797-908X
Robertson, Chris
Penna, Gerson O. https://orcid.org/0000-0001-8967-536X
Werneck, Guilherme L. https://orcid.org/0000-0003-1169-1436
Barreto, Maurício L.
Pearce, Neil https://orcid.org/0000-0002-9938-7852
Sheikh, Aziz https://orcid.org/0000-0001-7022-3056
Barral-Netto, Manoel
Boaventura, Viviane S. https://orcid.org/0000-0002-7241-6844
Article History
Received: 3 December 2021
Accepted: 14 January 2022
First Online: 9 February 2022
Competing interests
: S.V.K. was a member of the UK Government’s Scientific Advisory Group on Emergencies subgroup on ethnicity and the Cabinet Office’s International Best Practice Advisory Group and was co-chair of the Scottish Government’s Expert Reference Group on Ethnicity and COVID-19. C.R. reports grants from the Medical Research Council and Public Health Scotland during the conduct of the study and is a member of the Scottish Government Chief Medical Officer’s COVID-19 Advisory Group, the Scientific Pandemic Influenza Group on Modelling and the Medicines and Healthcare Products Regulatory Agency Vaccine Benefit and Risk Working Group. A.S. is a member of the Scottish Government Chief Medical Officer’s COVID-19 Advisory Group and its Standing Committee on Pandemics. A.S. is also a member of the UK Government’s New and Emerging Respiratory Virus Threats Risk Stratification Subgroup. V.d.A.O., V.S.B., M.L.B. and M.B.-N. are employees of Fiocruz, a federal public institution, which manufactures Vaxzevria in Brazil through a full technology transfer agreement with AstraZeneca. Fiocruz allocates all its manufactured products to the Ministry of Health for the public health service use. All other authors declare no competing interests.